Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
PCEP enhances IgA mucosal immune responses in mice following different immunization routes with influenza virus antigens.
Eng NF, Garlapati S, Gerdts V, Babiuk LA, Mutwiri GK.
J Immune Based Ther Vaccines. 2010 Aug 24;8:4.
Related citations
Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
Mutwiri G, Benjamin P, Soita H, Babiuk LA.
Vaccine. 2008 May 23;26(22):2680-8. Epub 2008 Apr 3.
Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens.
Mutwiri G, Benjamin P, Soita H, Townsend H, Yost R, Roberts B, Andrianov AK, Babiuk LA.
Vaccine. 2007 Jan 26;25(7):1204-13. Epub 2006 Oct 17.
Systemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine.
Shen X, Lagergård T, Yang Y, Lindblad M, Fredriksson M, Holmgren J.
Infect Immun. 2000 Oct;68(10):5749-55.
[The study for the immuno-protection of E. coli O157:H7 outer membrane protein].
Zhang Y, Lu SQ, Zhang YZ, Zhao BX, Xu JG.
Zhonghua Yi Xue Za Zhi. 2004 Jan 2;84(1):58-62. Chinese.
Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice.
Lu B, Huang Y, Huang L, Li B, Zheng Z, Chen Z, Chen J, Hu Q, Wang H.
Immunology. 2010 Jun;130(2):254-61. Epub 2010 Apr 6.
Effects of the nature of adjuvant and site of parenteral immunization on the serum and mucosal immune responses induced by a nasal boost with a vaccine alone.
Guy B, Fourage S, Hessler C, Sanchez V, Millet MJ.
Clin Diagn Lab Immunol. 1998 Sep;5(5):732-6.
Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target.
Manocha M, Pal PC, Chitralekha KT, Thomas BE, Tripathi V, Gupta SD, Paranjape R, Kulkarni S, Rao DN.
Vaccine. 2005 Dec 1;23(48-49):5599-617. Epub 2005 Jul 27.
Protective efficacy of rotavirus 2/6-virus-like particles combined with CT-E29H, a detoxified cholera toxin adjuvant.
Siadat-Pajouh M, Cai L.
Viral Immunol. 2001;14(1):31-47.
Route and method of delivery of DNA vaccine influence immune responses in mice and non-human primates.
McCluskie MJ, Brazolot Millan CL, Gramzinski RA, Robinson HL, Santoro JC, Fuller JT, Widera G, Haynes JR, Purcell RH, Davis HL.
Mol Med. 1999 May;5(5):287-300.
Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.
Strindelius L, Filler M, Sjöholm I.
Vaccine. 2004 Sep 9;22(27-28):3797-808.
Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses.
Campo JD, Zayas C, Romeu B, Acevedo R, González E, Bracho G, Cuello M, Cabrera O, Balboa J, Lastre M.
Methods. 2009 Dec;49(4):301-8. Epub 2009 May 4.
Human immune responses to influenza virus vaccines administered by systemic or mucosal routes.
Moldoveanu Z, Clements ML, Prince SJ, Murphy BR, Mestecky J.
Vaccine. 1995 Aug;13(11):1006-12.
Intranasal immunization with liposome-formulated Yersinia pestis vaccine enhances mucosal immune responses.
Baca-Estrada ME, Foldvari MM, Snider MM, Harding KK, Kournikakis BB, Babiuk LA, Griebel PP.
Vaccine. 2000 Apr 28;18(21):2203-11.
Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant.
Di Tommaso A, Saletti G, Pizza M, Rappuoli R, Dougan G, Abrignani S, Douce G, De Magistris MT.
Infect Immun. 1996 Mar;64(3):974-9.
Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice.
Liu XS, Abdul-Jabbar I, Qi YM, Frazer IH, Zhou J.
Virology. 1998 Dec 5;252(1):39-45.
Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution.
McCluskie MJ, Weeratna RD, Davis HL.
Mol Med. 2000 Oct;6(10):867-77.
Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes.
Sasaki S, Sumino K, Hamajima K, Fukushima J, Ishii N, Kawamoto S, Mohri H, Kensil CR, Okuda K.
J Virol. 1998 Jun;72(6):4931-9.
Mucosal IgA responses in healthy adult volunteers following intranasal spray delivery of a live attenuated measles vaccine.
Simon JK, Ramirez K, Cuberos L, Campbell JD, Viret JF, Muñoz A, Lagos R, Levine MM, Pasetti MF.
Clin Vaccine Immunol. 2011 Mar;18(3):355-61. Epub 2011 Jan 12.
A modified cholera holotoxin CT-E29H enhances systemic and mucosal immune responses to recombinant Norwalk virus-virus like particle vaccine.
Periwal SB, Kourie KR, Ramachandaran N, Blakeney SJ, DeBruin S, Zhu D, Zamb TJ, Smith L, Udem S, Eldridge JH, Shroff KE, Reilly PA.
Vaccine. 2003 Jan 17;21(5-6):376-85.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on